... WK,Tran H, Tsao A, Xie D, Ramies DA, Mass R, Seshagiri S, Eberhard DA,Kelley SK, Sandler A: Phase I/II trial evaluating the anti-vascularendothelial growth factor monoclonal antibody bevacizu-mab ... Biological agents in non- small cell lung can-cer: a review of recent advances and clinical results with a focus on epidermal growth factor receptor and vascularendothelial growth factor. J Thorac ... RS, Manegold C, Fukuoka M, KrisMG, Baselga J, Ochs JS, Haber DA: Epidermal growth factor receptor mutations and gene amplification in non- small- cell lung cancer: molecular analysis of the IDEAL/INTACT...